Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1044 | 1045 | (Page 1046) | 1047 | 1048 | .... | 1118 | newer

    0 0

    (EMAILWIRE.COM, May 26, 2018 ) Global Wearable Insulin Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

    Global Wearable Insulin Devices Market: By Product Type (Patches and Pods), By Age Group (Adults and Pediatrics), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

    Global wearable insulin devices market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

    Market Outline: Wearable Insulin Devices Market
    Wearable insulin devices are the medical devices that helps in controlling or maintaining the blood glucose in the patient’s body. The insulin is the major part in the treatment of diabetes. Insulin is the hormone made by the pancreas which allows the body to use or store the sugar or the glucose from carbohydrates form the food. It allows to maintain the blood sugar level form either getting too high, which would result in hyperglycemia or from getting too low which would result in hypoglycemia.

    Market Dynamics: Wearable Insulin Devices Market
    Increase in the prevalence of diabetes is the major factor anticipated to drive the growth of wearable insulin devices market. Increasing health issues such as obesity and launch technologically advanced devices anticipated to fuel the growth of wearable insulin devices market. The rising awareness among the patient population with regard to advanced treatment options and increasing healthcare expenditure are expected to boost the wearable insulin devices market. The adoption of the self-care diabetes management methods and increasing R&D activities are providing opportunity to the manufacturers to further expansion of the market. However, the high cost of the device may hamper the growth of the wearable insulin devices market.

    Free sample of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-4H8Z4LpNMLEuOnnx


    Market Scope: Wearable Insulin Devices Market
    Wearable insulin devices market is segmented based on the product type, age group, and distribution channel
    Based on the product type, the market is segmented into the following:
    • Patches
    • Pods
    Based on the age group, the market is segmented into the following:
    • Adults
    • Pediatrics
    Based on the distribution channel, the market is segmented into the following:
    • Hospital Pharmacies
    • Online Pharmacies
    • Others

    Free TOC of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-c654SbFYO64MsOhu


    Regional Analysis: Wearable Insulin Devices Market
    Geographically, global wearable insulin devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America wearable insulin devices market is dominant when compared with that of the other regional markets owing to favorable reimbursement policies and increase in the prevalence of diabetes and obesity. According to the Centers for Disease Control and Prevention (CDC) in the year of 2016, there were 29 million patients in U.S. who are still suffering with diabetes, of which 21.0 million patients were diagnosed and 8.1 million patients are undiagnosed. The increasing awareness about the self-treatment procedures is also enhancing the growth of the wearable insulin devices market. The Asia Pacific is the region expected to offer lucrative growth opportunities owing to large untapped market and availability of large diabetic patient pool in India and China.

    Ask Analyst for Full Information about this report @https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-14mlyhjMGhVjZqa3


    Competition Assessment: Wearable Insulin Devices Market
    Some of the players in the global wearable insulin devices market include:
    • Omnipod (U.S)
    • Valeritas, Inc. (U.S)
    • CeQur (Switzerland)
    • Prometheon Pharma (U.S)
    • Sproutel (U.S)
    • MedicSen (Spain)

    Notable Market Developments: Wearable Insulin Devices Market
     In January 2018, Valeritas launches V-Go wearable insulin delivery device in Puerto Rico.

    Get access to full summary @https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/


    About Precision Business Insights
    Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
    Contact to Precision Business Insights,
    Kemp House,
    152 – 160 City Road,
    London EC1V 2NX
    Email: sales@precisionbusinessinsights.com
    Toll Free (US):+1-866-598-1553
    Website @https://www.precisionbusinessinsights.com




    Satya
    +1-866-598-1553
    satya@pbigp.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 26, 2018 ) South Korea Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market.

    South Korea proton therapy market is anticipated to almost three-fold during the period 2016 - 2022. The number of patients treated with Proton Therapy in South Korea is very low whereas; the potential candidates for proton therapy are huge. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. Hence, many research institutions and hospitals have now started investing in proton therapy to make it more accessible to patients.

    Get Sample Pages @  http://orbisresearch.com/contacts/request-sample/276172

    Report has been analyzed from 4 View Points:
    1. Actual and Potential Proton Therapy Market (2007 - 2022)
    2. Actual and Potential Candidate for Proton Therapy Treatment (2007 - 2022)
    3. List of Proton Therapy Centers
    4. Proton Therapy Market - Drivers and Challenges

    Make an Enquiry @ http://orbisresearch.com/contacts/enquiry-before-buying/276172

    Few Major Points Of TOC :

    1. Executive Summary

    2. South Korea Proton Therapy Market Analysis
    2.1 South Korea Proton Therapy - Actual and Potential Market (2007 - 2022)
    2.1.1 South Korea - Actual Proton Therapy Market and Forecast
    2.1.2 South Korea - Potential Proton Therapy Market and Forecast
    2.2 South Korea Proton Therapy Patients Number - Actual and Potential (2007 - 2022)
    2.2.1 South Korea - Patients Treated with Proton Therapy Actual Number and Forecast
    2.2.2 South Korea - Potential Candidate for Proton Therapy Number and Forecast

    3. South Korea - List of Proton Therapy Centers, Start of Treatment, Patient Treated

    4. South Korea – Number of Patients Treated at Proton Therapy Centers
    4.1 Korean National Cancer Center - Number of Patients Treated (2007 – 2015)
    4.2 Samsung Proton Center - Number of Patients Treated (2015)

    5. Current Radiation Therapies
    5.1 Third Dimensional Conformal Therapy (CRT)
    5.2 Image Guided Radiotherapy (IGRT)
    5.3 Intensity Modulated Radiotherapy (IMRT)
    5.4 Stereotactic Radiotherapy
    5.5 Neutron Therapy
    5.6 Heavy Ion Radiotherapy
    5.7 Proton Therapy

    6. Components of a Standard Proton Therapy Center
    6.1 Proton Accelerator
    6.2 Beam Transport System
    6.3 Beam Delivery System
    6.3.1 The Passive Scattering Technique
    6.3.2 Beam Scanning
    6.4 Nozzle
    6.4.1 Single Scattering
    6.4.2 Double Scattering
    6.4.3 Uniform Scanning Nozzle
    6.4.4 Pencil Scanning Nozzle
    6.5 Treatment Planning System
    6.6 Image Viewers
    6.7 Patient Positioning System (PPS)
    6.8 Human Resource

    7. Proton Therapy - Driving Factors
    7.1 Technology Advancement
    7.1.1 Next-Generation Proton Technique
    7.1.2 Technological Advances Make Proton Therapy Centers More Scalable
    7.2 Growing Incidence of Cancer Patients
    7.3 Proton Therapy Provides Enormous Benefits

    8. Proton Therapy - Challenges
    8.1 Requires Huge Investment
    8.2 Operations Challenges
    8.3 More Clinical Evidence Is Needed

    Browse Full Report @  http://orbisresearch.com/reports/index/south-korea-proton-therapy-market-actual-and-potential-patients-treated-list-of-proton-therapy-centers-and-forecast-to-2022

    About Us:

    Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


    Hector Costello
    +1 (214) 884-6817
    sales@orbisresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 28, 2018 ) The report "Aesthetic/Cosmetic Lasers Market by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye), Multiplatform), by Application (Acne, Scars, Tattoo Removal, Varicose Veins), by End User (Hospitals, Medical Spa, Private clinics) - Forecasts to 2021", provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the aesthetic/cosmetic lasers market along with the estimates and forecasts of the revenue.

    Growth in the adoption of non-invasive cosmetic procedures, changing lifestyle and increasing disposable income, advancements in technology, and rising medical tourism are the major drivers of the aesthetic/cosmetic lasers market. However, lack of reimbursement will restrain the growth of this market.

    Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=94673613

    The aesthetic/cosmetic lasers market is segmented on the basis of type, application, end user, and region. Based on type, the aesthetic/cosmetic lasers type market is categorized into standalone lasers and multiplatform lasers. In this market, multiplatform lasers form the fastest-growing segment as they provide scalable and upgradeable hybrid systems that can treat multiple indications. Furthermore, the standalone lasers market is divided into carbon dioxide (CO2) lasers, Er:YAG lasers, diode lasers, pulsed dye lasers, nd:YAG lasers, alexandrite lasers, and other standalone lasers (argon, ruby, krypton lasers, and erbium:glass lasers).

    Based on application, the aesthetic/cosmetic lasers type market is categorized into vascular lesions, acne, & scars, pigmented lesions & tattoos, hair removal, skin rejuvenation, leg veins & varicose veins, and other applications (onychomycosis and gynaecological conditions). The hair removal segment is expected to account for the largest share of the aesthetic/cosmetic lasers market in 2016. Factors such higher adoption of aesthetic procedures, development in the laser technology, increased focus on body appearance by both men and women, high disposable income are driving the growth of this segment in the market.

    Based on end user, the aesthetic/cosmetic lasers type market is categorized into hospitals, private clinics, and medical spas. The private clinics segment is estimated to account for the highest growth of the market in 2016, due to factors such as increasing demand for cosmetic procedures from baby boomer population, adoption of new technologies, increasing preference for noninvasive procedures, reduced cost for laser based treatments, and higher disposable income in emerging economies.

    North America is expected to account for the largest share of the aesthetic/cosmetic lasers market in 2016. The Asia-Pacific region accounted for the second-largest share of the aesthetic/cosmetic lasers market; in this region the availability of R&D funds has encouraged the aesthetic/cosmetic lasers market. The Asia-Pacific region is estimated to be the fastest growing region in the aesthetic/cosmetic lasers market during the forecast period owing to changing lifestyles, rising incidences of skin damage, and increasing medical tourism.

    Major players in the aesthetic/cosmetic lasers market include are Aerolase (U.S.), Alma Lasers (Israel), Cutera, Inc. (U.S.), Cynosure (U.S.), El.En. SpA (Italy), Lumenis Ltd. (Israel), Sciton Inc. (U.S.), SharpLight Technologies (Israel), Syneron Medical Ltd. (Israel), and Solta Medical (U.S.).



    Mr. Rohan
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 28, 2018 ) According to a new market research report "Gene Expression Analysis Market by Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics) & Applications (Research, Drug Discovery, Diagnostic) - Global Forecasts to 2020", published by MarketsandMarkets, This report studies the global market for the forecast period of 2015 to 2020. This market is expected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3%.

    Factors such as availability of funding, growing number of cancer patients, strong focus on research, and decreasing cost of sequencing are driving growth in this market. Furthermore, increased focus on personalized medicines and room for market penetration in emerging nations is expected to create an array of opportunities for players in the gene expression analysis market.

    Download Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=156613968

    The global gene expression analysis market is segmented on the basis of consumables, instruments, services, applications, and region.

    Based on consumables, the market is categorized into reagents and DNA chips. In 2015, the reagents segment accounted for the larger share of the gene expression analysis consumables market. The high growth and dominant market size of the reagents segment can be attributed to the increased number of gene expression analysis instrument installations, favorable funding scenario promoting research initiatives, and growing number of sequencing services centers

    On the basis of instruments, the market is segmented based on technology such as PCR, NGS, DNA Microarray, SAGE, and Northern Blotting. The PCR segment accounted for the largest share of the gene expression analysis in 2015. However, the NGS segment is expected to be the fastest growing segment from 2015 to 2020. Factors such as the need to enhance knowledge of DNA sequences, wide application base, continued technological advancements aimed at improving the speed and throughput, and increase in large-scale gene expression studies are driving growth of the NGS segment.

    Based on services, the market is segmented into gene expression profiling services and bioinformatics solutions. The gene expression profiling services segment accounted for the largest share of the gene expression analysis market in 2015. The gene expression profiling services segment is also expected to be the fastest growing segment from 2015 to 2020. The insights obtained through gene expression profiling plays a vital role in the advancement of disease diagnosis, drug discovery, and precision medicine. This is expected to boost the demand for gene expression profiling services in the coming years.

    Free Report Sample: https://www.marketsandmarkets.com/requestsample.asp?id=156613968

    The market on the basis of application is categorized into research, drug discovery, diagnostic, and others. Others comprise of animal research, agricultural research, and forensics. In 2015, the research segment accounted for the larger share of the gene expression analysis market and expected to grow at the fastest rate during the forecast period. The large share of the research segment can be attributed to the availability of funding for research at institutional and academic level.

    On the basis of regions, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, and the Middle East & Africa). In 2015, North America accounted for the largest share of the gene expression analysis market, followed by Europe and Asia. Asia-Pacific is expected to grow at the fastest rate during the forecast period. Growth in this region can be attributed to increasing research activities on agriculture, government intervention to improve healthcare, and rising popularity of gene expression tests.

    However, the high cost of the major gene expression analysis instruments is a major concern, which limits market growth to a certain extent. Also, the currency devaluations in developing countires are expected to pose as a key challenge to the growth of the gene expression analysis market.

    Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), and PerkinElmer (U.S.) are some of the major players in gene expression analysis market.

    Contact:
    Mr. Rohan
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA : 1-888-600-6441
    sales@marketsandmarkets.com


    Mr. Rohan
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 26, 2018 ) Virtual reality (VR) is a computer-generated scenario that simulates experience through senses and perception. The immersive environment can be similar to the real world or it can be fantastical, creating an experience not possible in our physical reality. Augmented reality systems may also be considered a form of VR that layers virtual information over a live camera feed into a headset or through a smartphone or tablet device giving the user the ability to view three-dimensional images.

    The Virtual Reality in Healthcare market estimate is anticipated to develop at a Compound Annual Growth Rate (CAGR) of +54%.

    The report presents an overview of the existing market, presents an exhaustive analysis of various dynamics such as drivers, trends, restraints, and opportunities. It also provides valuation and prospects of various segments, and finishes off with a view of the competitive landscape by profiling a number of players who are currently holding a position of strength in the Virtual Reality in Healthcare Market.

    Get Sample copy of this report @: http://qyreports.com/request-sample?report-id=52546

    Companies Profiled in this report includes, Virtalis Ltd, CAE Healthcare, GE Healthcare, Virtual Realities Ltd, Qualcomm Technologies, Inc., Samsung, Vuzix Corporation, Mimic Technologies Inc, WorldViz, LLC., and Brainlab AG.

    According to the research report, the Global Virtual Reality in Healthcare Market has been witnessing a substantial increase in its valuation and size. The significant rise in the industry and the subsequent surge in exploration activities is boosting the demand for the market across the world. Researchers predict the scenario to remain so over the next few years, notes the study.

    The global virtual reality in the healthcare market is segmented on the basis of technology, application and geography. On the basis of technology, the market is segmented into, Full Immersive VR, Semi-Immersive VR and Non- Immersive VR. The market, on the basis of application segmented into Surgery simulation, Phobia treatment, Robotic surgery, Education and Training, Visualization and Rehabilitation, Treatment of Post-Traumatic Stress Disorder (PTSD), Treatment of Autism, Diagnosis of cognitive disorders and others.

    Avail 20% Discount on this report @: http://qyreports.com/ask-for-discount?report-id=52546

    The major players of the Virtual Reality in Healthcare market are identified across regions, and their offerings, distribution channels, and regional presence are understood through in-depth discussions. Also, average revenue generated by these companies, segmented on the basis of region, is used to arrive at the overall market size. This overall market size is used in the top-down procedure to estimate the sizes of other individual markets through percentage splits from secondary sources directories, databases, and primary research.

    Further, the study offers an analysis of the current performance of the key regional markets for Virtual Reality in Healthcare, namely Europe, Latin America, North America, the Middle East and Africa, and Asia Pacific, on the basis of a number of imperative market parameters, such as, the manufacturing volume, production capacity, pricing strategy, the dynamics of demand, supply, and sales, return on investments (RoI), and the growth rate of this market in each of the regions.

    For More Information @: http://qyreports.com/enquiry-before-buying?report-id=52546

    Significant Highlights of the Report:
    • A pure assessment of the orbit of the market
    • Studies on the evolving Global Virtual Reality in Healthcare market segments regions
    • Market shares and strategies of leading players that are involved in the market
    • Market segmentation up to the last level
    • A point-to-point assessment of the market development
    • Historical, present, and future size of the market from the perspective of both value and volume
    • Suggestions to the companies to establish their foothold in the market

    Table of Contents
    Global Virtual Reality in Healthcare Market Research Report
    Chapter 1 Virtual Reality in Healthcare Market Overview
    Chapter 2 Global Economic Impact on Industry
    Chapter 3 Global Market Competition by Manufacturers
    Chapter 4 Global Production, Revenue (Value) by Region
    Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
    Chapter 6 Global Production, Revenue (Value), Price Trend by Type
    Chapter 7 Global Market Analysis by Application
    Chapter 8 Manufacturing Cost Analysis
    Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    Chapter 10 Marketing Strategy Analysis, Distributors/Traders
    Chapter 11 Market Effect Factors Analysis
    Chapter 12 Global Virtual Reality in Healthcare Market Forecast



    Jones John
    +91-9764607607
    sales@qyreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 26, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Capsule Endoscopes Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-capsule-endoscopes-sales-market-report-2018
    Global Capsule Endoscopes Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Given Imaging
    • Medtronic
    • Olympus
    • Chongqing Jinshan Science & Technology
    • Intromedic
    • Capsovision
    • Rf System Lab
    • Check-Cap
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/879345
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Small Bowel Capsule
    • Esophageal Capsule
    • Colon Capsule
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Capsule Endoscopes Sales for each application, including
    • Obscure Gastrointestinal Bleeding (OGIB)
    • Crohn's Disease
    • Others
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/879345


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 26, 2018 ) The “Global Tele-Intensive Care Unit Market Analysis to 2025” is a specialized and in-depth study of the Tele-Intensive Care Unit industry with a focus on the global market trend. The report aims to provide an overview of global tele-intensive care unit market with detailed market segmentation by type, component and geography. The global tele-intensive care unit market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    FREE |Request Sample Copy of Tele-Intensive Care Unit Market @https://tinyurl.com/yc44nkzz



    This report focuses on the top players in global market, like

    InTouch Technologies, Inc.
    Advanced ICU Care
    Koninklijke Philips N.V.
    UPMC
    Banner Health
    TeleICUCare
    Eagle Telemedicine
    Apollo Tele Health Services
    SOC Telemed
    INTeleICU
    The tele-intensive care unit market is segmented based on type as, centralized, decentralized, and other models. Based on the component, the tele intensive care unit market is segmented as hardware and software. The segment of hardware is further classified as video display panels, communication lines, therapeutic devices, computer systems, and others such as medicals records, video feeds among others.

    Ask for Discount @https://tinyurl.com/y9svd8ll

    Tele-Intensive Care ICU (Tele-ICU) is an application of telemedicine that deals with critical care of a patient in a hospital. Tele-ICU aids in connecting the critical care team at a distant location with the bedside ICU team with the help of audiovisual communication and monitoring systems. A Tele-ICU system comprises of hardware which collects the patient’s data and transmits from the remote ICU to the physician at a distant location through a command center. The data collected and transmitted by the ICU system includes patient’s physiological status, treatment and medical records.

    Rise in the number of intensive care units globally and incessant technological advancements in remote patient monitoring technologies are anticipated to drive the tele intensive care unit market during the coming years. Increase in the number of chronic disease cases and the need to reduce hospital stay times are expected to promote growth of the Tele-ICU market during the forecast period.

    The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global tele-intensive care unit market based on type and component. It also provides market size and forecast till 2025 for overall tele-intensive care unit market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

    North America is anticipated to witness significant growth in the tele intensive care unit market during the forecast period. The market in North America is expected to grow owing to various developments in the field of telemedicine. During the forecast period, the demand for tele intensive care units in Asia Pacific is expected to grow at a significant rate. Government initiatives promoting telehealth in countries such as China and India is expected to drive the overall market in Asia Pacific during the coming years.

    The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    The report also includes the profiles of key tele-intensive care unit manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are InTouch Technologies, Inc., Advanced ICU Care, Koninklijke Philips N.V., UPMC, Banner Health, TeleICUCare, Eagle Technologies, Apollo Tele Health Services, SOC Telemed, and INTeleICU among others.

    Else place an Inquire before Purchase “Global Tele-Intensive Care Unit Market Size, Status and Forecast 2025 “@https://tinyurl.com/ycy2y4d2



    (Note: If you have any special requirements, please let us know and we will offer you the report as you want.)


    Sameer Joshi
    +91 9666111581
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 26, 2018 ) Continuous blood glucose monitoring system is a medical device which is used to track and monitor glucose levels in the blood. This system will help the patients to continuously track & monitor the fluctuations in the sugar level. The various components of continuous blood glucose monitoring system are insulin pumps, sensors, and transmitters and receivers among other to monitor it in real time.

    The mounting inclination of patients towards real-time health monitoring and availability of reliable, frequent, and real time track assistance are the major drivers which are likely to propel the growth of continuous blood glucose monitoring system market. Increase in the prevalence of diabetic patients, rising attention towards health awareness, and increasing affordability of devices are likely to add new opportunities for this market in the coming years.

    FREE | Request Sample Copy is Available at@ http://www.theinsightpartners.com/sample/TIPHE100000865?source=Mudassar

    The “Global Continuous Blood Glucose Monitoring System Market Analysis to 2025” is a specialized and in-depth study of the continuous blood glucose monitoring system industry with a focus on the global market trend. The report aims to provide an overview of global continuous blood glucose monitoring system market with detailed market segmentation by components, testing sites, application, and geography. The global continuous blood glucose monitoring system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    The continuous blood glucose monitoring system market is segmented based on components which is further sub- segmented into the insulin pumps, sensors, and transmitters and receivers. The testing site segment is sub divided into alternate site testing, fingertip, and others. Some of the key applications of continuous blood glucose monitoring system are Type 1 diabetic patients, Type 2 diabetic patients, gestational diabetes, and critical care patients, among others.

    North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.

    key development in past five years. Some of the key players influencing the market Dexcom, Inc., Abbott, Bayer AG, F. Hoffmann-La Roche, Arkray Inc., Cellnovo, Echo Therapeutics Inc., Nemaura, Tandem Diabetes Care, Inc., and PharmaTech Solutions, Inc. among Others.

    1 Introduction

    2 Key Takeaways

    3 Continuous Blood Glucose Monitoring Market Landscape

    4 Continuous Blood Glucose Monitoring Market – Key Industry Dynamics

    5 Continuous Blood Glucose Monitoring Market Analysis- Global

    6 Continuous Blood Glucose Monitoring Market –Global Regulatory Scenario

    7 Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2025 – Components (US$ Mn)

    9 Continuous Blood Glucose Monitoring Market Revenue and Forecasts to 2025 – Applications (US$ Mn)

    Inquire For Reports At:- http://www.theinsightpartners.com/inquiry/TIPHE100000865?source=Mudassar


    Sameer Joshi
    +91 9666111581
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 27, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Lighted Mirror Medicine Cabinets Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-lighted-mirror-medicine-cabinets-sales-market-report-2018
    Global Lighted Mirror Medicine Cabinets Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Kohler
    • Robern
    • Jensen
    • Afina
    • Ketcham Medicine Cabinets
    • American Pride
    • Bradley
    • Strasser
    • Croydex
    • Design House
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/877528
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Plane Mirror
    • Curved Mirror
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Lighted Mirror Medicine Cabinets Sales for each application, including
    • Hospitals
    • Clinics
    • Other
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/877528


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 27, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Parenteral Nutrition Products Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-parenteral-nutrition-products-sales-market-report-2018
    Global Parenteral Nutrition Products Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Baxter International
    • Hospira
    • B. Braun Melsungen
    • Grifols International
    • Fresenius Kabi
    • Otsuka Pharmaceutical Factory
    • Actavis
    • Sichuan Kelun Pharmaceutical
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/877579
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Carbohydrates
    • Parenteral Lipid Emulsion
    • Single Dose Amino Acid Solution
    • Trace Elements
    • Vitamins and Minerals
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Parenteral Nutrition Products Sales for each application, including
    • Premature Infants,Neonates and Children
    • Geriatrics
    • Chronic Disease Patients
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/877579


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 27, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Children Orthopedic Shoes Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-children-orthopedic-shoes-sales-market-report-2018
    Global Children Orthopedic Shoes Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Healthyfeetstore
    • Hatchbacks
    • Memo-Shoes
    • New Balance
    • Dr. Comfort
    • Mephisto
    • Apex
    • Propet
    • Vionic
    • Chaneco
    • Duna
    • Orthofeet
    • Piedro
    • Darco
    • Drew Shoe
    • Sole
    • Rokab
    • Lxtd
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/918180
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Under 5 years old
    • 5 years old to 12 years old
    • Above 12 years old
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Children Orthopedic Shoes Sales for each application, including
    • Varus Foot
    • Valgus
    • Equinus
    • Other
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/918180


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 27, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hydroxyurea Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-hydroxyurea-sales-market-report-2018
    Global Hydroxyurea Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Bristol-Myers Squibb
    • Euticals
    • Tecoland
    • Qilu Tianhe Pharmaceutical
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/915641
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Oral
    • Intravenous
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Hydroxyurea Sales for each application, including
    • Chronic Myelogenous Leukemia
    • Myeloproliferative Disease
    • Sickle Cell Anemia
    • Other
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/915641


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 28, 2018 ) APPLE VALLEY, MN – Brite Smiles Dental Care ( http://www.britesmilesdentalcare.com ), in Apple Valley, is offering their advice on how to floss under a bridge or how to floss with complex dental work.

    Brite Smile’s advice is the following:

    Brush your teeth as you normally would. If you have a regular or an implant bridge, you can brush as if you were brushing natural teeth. After brushing, you can use a Proxabrush, a device that is like a toothpick with a brush on the end. You place the Proxabrush between the teeth or under the bridge at the gum level and saw it back and forth comfortably. You can use the Proxabrush around your natural teeth as well, especially if flossing is becoming hard. Don’t push too hard to fit the Proxabrush in between the teeth; use it wherever it will fit in between the teeth.

    Superfloss is used like regular floss, but it has a stiffer side to get under a bridge. Floss as normal, pulling the remaining floss out. To use the floss threader, place the floss through the hole and place the threader under the bridge and floss as normal, pulling the remaining floss out.

    Linda B., a patient at Brite Smiles, said, “I came to your office because I am interested in good, reputable dental care and was very adequately pleased. My questions and concerns were addressed thoroughly and concisely. All staff were very responsive and professional. Thank you.”

    Dr. Dennis Simmons graduated from the University of Minnesota School of Dentistry in 1976, receiving the Class Honor in prosthetics – dentures partial and full. Since then, he has participated in over 3,000 hours of continuing education courses, focusing primarily on cosmetic and reconstructive surgery, dental implants and implant-supported restorations, orthodontics, extractions, crown/bridge, root canals, bite and TMJ disorders and sleep apnea. For his studies, he has been honored with the status of “Diplomate” from the International Congress of Oral Implantology and the International Osseous (bone) Integration Society. For more information on dental services from Brite Smiles Dental Care, visit http://britesmilesdentalcare.com, or call 952-891-8484.


    Dr. Dennis Simmons
    6614412429
    brite.smiles.dental.mn@gmail.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 29, 2018 ) This report studies the endoscopy video processors market; endoscopy video processors are used for endoscopic images in HDTV or HD quality.

    Scope of the Report:
    This report focuses on the Endoscopy Video Processors in AsiaPacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.

    Market Segment by Manufacturers, this report covers
    Olympus
    FUJIFILM
    Stryker
    KARL STORZ
    HOYA
    Richard Wolf
    Boston Scientific
    XION Medical
    Tian Song
    Shenda Endoscope
    Sonoscape Company
    Kanger Medical
    HUGER
    Mindray
    AOHUA

    Get More Information about this Report @ https://www.planetmarketreports.com/reports/asiapacific-endoscopy-video-processors-market-2229

    Market Segment by Countries, covering
    China
    Japan
    Korea
    Taiwan
    Southeast Asia
    India
    Australia

    Market Segment by Type, covers
    Video Processors without Display
    Video Processors with Display

    Market Segment by Applications, can be divided into
    Upper GI Endoscopy
    Colonoscopy
    Bronchoscopy
    Sigmoidoscopy
    ENT Endoscopy
    Others

    There are 19 Chapters to deeply display the AsiaPacific Endoscopy Video Processors market.

    Chapter 1, to describe Endoscopy Video Processors Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

    Chapter 2, to analyze the manufacturers of Endoscopy Video Processors, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;


    To be continue….!!!

    To Browse Similar Reports @ http://www.planetmarketreports.com/category/medical-devices

    About Us :

    Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe. We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.

    We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.

    Contact Us :
    Name: Ronald James
    Email-Id: ronald.james@planetmarketreports.com
    US : +1-716-2260907
    UK : +447441952057
    Organization: Planet Market Reports



    Himesh Khatri
    9834406269
    himesh@planetmarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 29, 2018 ) “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical

    Non-clinical

    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/angiotensin-ii-receptor-type-2-at2-receptor-inhibitor-pipeline-insight-2018/3026024

    Descriptive coverage of pipeline development activities for “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor

    The report assesses the active Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/3026024

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/3026024

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor

    Features the Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor pipeline across the complete product development cycle including all clinical and non-clinical stages

    Offers detailed therapeutic product profiles of Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

    Coverage of dormant and discontinued pipeline projects across “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor

    Discount before buying @ https://www.researchcosmos.com/discount/3026024

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor to formulate effective R&D strategies

    Assess challenges and opportunities that influence Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor research & development (R&D)

    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

    Identify and understand the sought after therapy areas and indications for “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor

    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor to enhance and expand business potential and scope

    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 29, 2018 ) Global Report of Cancer Biomarker Testing Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2016 and Forecast 2017-2024

    Global Cancer Biomarker Testing Market:
    Biomarker testing also known as genetic testing or molecular testing are group of tests that look for these molecular signs of health so that doctors can plan best care. Biomarker is any of body’s molecules that can be measured to assess the health. Molecules can be obtained from, body fluids, tissue or blood. Cancer biomarker is a process or substance that indicates the presence of cancer in the body as abnormal growth of cells. Genetic, epigenetic, glycemic, proteomic, and imaging biomarkers are used for cancer diagnosis, prognosis, and epidemiology. These cancer biomarkers used as risk indicators for various types of cancer such as lung cancer, breast cancer and prostate cancer among the others.

    The number of new cases is expected to rise about 70% over the coming 2 decades. In addition, increase in awareness in public and healthcare professionals regarding early diagnostic procedures, rise in government and NGO’s funding for oncology are expected to grow the cancer biomarker testing market. However, high cost for biomarker tests, low detection rates and regulatory policies are expected to hamper the cancer biomarker test market.

    Free sample of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-4H8Z4LpNMLEuOnnx


    The cancer biomarker testing market is categorized on the basis of-
    1. Type of cancer
    • Cervical cancer
    • Lung Cancer
    • Collateral Cancer
    • Liver Cancer
    • Prostate Cancer
    • Breast Cancer
    • Others
    2. Applications
    • Drug Discovery and Development
    • Personalized Medicine
    • Diagnosis
    • Others
    3. End-users
    Hospitals, Cancer diagnostic centers, research institutes and others.

    Free TOC of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-c654SbFYO64MsOhu


    And lastly on the basis of geographical regions, the global cancer biomarker testing market have five major regions- North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is a major market due to increase in R & D activities for diagnosis and treating cancer and rise in prevalence of cancer. Asia-Pacific cancer biomarker test market is expected to be fastest growing market due to increase in demand for the non-invasive techniques in diagnosis and prevention of cancer, high prevalence of cancer conditions in the region.

    Some of the players in cancer biomarker test market are Thermo Fisher Scientific (Affymetrix Inc.) (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), AbbVie Inc. (U.S.), Arquer Diagnostics Ltd. (U.K.), Illumina, Inc. (U.S.), Qiagen (Germany), Agilent Technologies (U.S.), Merck & Co. Inc. (U.S.), Becton Dickinson and Company (U.S.), and Hologic Inc. (U.S.) to name a few. In 2015, Abbot Laboratories acquired exclusive rights for FGFR3 gene mutations to detect bladder cancer. It is a gene mutation and useful for early detection, disease monitoring, and prognosis of bladder cancer through tissue and urine-based testing.

    Ask Analyst for Full Information about this report @https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-14mlyhjMGhVjZqa3


    Market players are carrying out collaborations, partnerships, and acquisitions as key development strategies to enhance the market share. For instance, in March 2017, Foundation Medicine and Bristol-Myers Squibb entered collaboration to understand tumor profile and its microenvironment to predict patient’s response to cancer immunotherapy. Key cancer biomarkers include SCC, CEA, NSE Cyfra 21, PSA (prostate cancer), TPA (Lung cancer), CA15-3, EGF R, Cytokeratin 4 (breast cancer) and BRCA ½.

    Get access to full summary @https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/


    About Precision Business Insights
    Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
    Contact to Precision Business Insights,
    Kemp House,
    152 – 160 City Road,
    London EC1V 2NX
    Email: sales@precisionbusinessinsights.com
    Toll Free (US):+1-866-598-1553
    Website @https://www.precisionbusinessinsights.com





    Satya Satya
    866-598-1553
    satya@pbigp.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 29, 2018 ) “Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical

    Non-clinical

    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/angiotensin-ii-receptor-type-2-at2-receptor-modulator-pipeline-insight-2018/4925346

    Descriptive coverage of pipeline development activities for “Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

    The report assesses the active Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/4925346

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

    Features the Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator pipeline across the complete product development cycle including all clinical and non-clinical stages

    Offers detailed therapeutic product profiles of Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

    Coverage of dormant and discontinued pipeline projects across “Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

    Inquire before buying @ https://www.researchcosmos.com/inquire/4925346

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator to formulate effective R&D strategies

    Assess challenges and opportunities that influence Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator research & development (R&D)

    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

    Identify and understand the sought after therapy areas and indications for “Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator to enhance and expand business potential and scope

    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 29, 2018 ) Functional Nearinfrared Spectroscopy fNIRS is a device designed to detect changes in the concentration of oxygenated oxyHb and deoxygenated deoxyHb haemoglobin molecules in the blood, a method commonly used to assess cerebral activity. fNIRS is a type of functional neuroimaging technology that offers a relatively noninvasive, safe, portable, and lowcost method of indirect and direct monitoring of brain activity.

    Scope of the Report:
    This report focuses on the fNIRS Brain Imaging System in AsiaPacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.

    Market Segment by Manufacturers, this report covers
    Hitachi
    Shimadzu Corporation
    NIRx
    ISS
    Biopac
    Techen
    Artinis
    Gowerlabs
    Spectratech

    Get More Information about this Report @ https://www.planetmarketreports.com/reports/asiapacific-fnirs-brain-imaging-system-market-4477

    Market Segment by Countries, covering
    China
    Japan
    Korea
    Taiwan
    Southeast Asia
    India
    Australia

    Market Segment by Type, covers
    Desk Type
    Portable Type

    Market Segment by Applications, can be divided into
    University
    Hospital
    Research Institution
    Others

    There are 19 Chapters to deeply display the AsiaPacific fNIRS Brain Imaging System market.

    Chapter 1, to describe fNIRS Brain Imaging System Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

    Chapter 2, to analyze the manufacturers of fNIRS Brain Imaging System, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
    To be continue….!!!

    To Browse Similar Reports @ http://www.planetmarketreports.com/category/medical-devices
    About Us :
    Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe. We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.
    We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.
    Contact Us :
    Name: Ronald James
    Email-Id: ronald.james@planetmarketreports.com
    US : +1-716-2260907
    UK : +447441952057
    Organization: Planet Market Reports





    Himesh Khatri
    9834406269
    himesh@planetmarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 29, 2018 ) “Angiotensin Modulators - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Angiotensin Modulators development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical

    Non-clinical

    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/angiotensin-modulators-pipeline-insight-2018/4132681

    Descriptive coverage of pipeline development activities for “Angiotensin Modulators - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “Angiotensin Modulators

    The report assesses the active Angiotensin Modulators pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/4132681

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/4132681

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “Angiotensin Modulators

    Features the Angiotensin Modulators pipeline across the complete product development cycle including all clinical and non-clinical stages

    Offers detailed therapeutic product profiles of Angiotensin Modulators with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

    Coverage of dormant and discontinued pipeline projects across “Angiotensin Modulators

    Discount before buying @ https://www.researchcosmos.com/discount/4132681  

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across Angiotensin Modulators to formulate effective R&D strategies

    Assess challenges and opportunities that influence Angiotensin Modulators research & development (R&D)

    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

    Identify and understand the sought after therapy areas and indications for “Angiotensin Modulators

    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Angiotensin Modulators to enhance and expand business potential and scope

    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 29, 2018 ) “Angiotensin Receptor Agonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Angiotensin Receptor Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical

    Non-clinical

    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/angiotensin-receptor-agonist-pipeline-insight-2018/4686582

    Descriptive coverage of pipeline development activities for “Angiotensin Receptor Agonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “Angiotensin Receptor Agonist

    The report assesses the active Angiotensin Receptor Agonist pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/4686582

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/4686582

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “Angiotensin Receptor Agonist

    Features the Angiotensin Receptor Agonist pipeline across the complete product development cycle including all clinical and non-clinical stages

    Offers detailed therapeutic product profiles of Angiotensin Receptor Agonist with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

    Coverage of dormant and discontinued pipeline projects across “Angiotensin Receptor Agonist

    Discount before buying @ https://www.researchcosmos.com/inquire/4686582   

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across Angiotensin Receptor Agonist to formulate effective R&D strategies

    Assess challenges and opportunities that influence Angiotensin Receptor Agonist research & development (R&D)

    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

    Identify and understand the sought after therapy areas and indications for “Angiotensin Receptor Agonist

    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Angiotensin Receptor Agonist to enhance and expand business potential and scope

    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

older | 1 | .... | 1044 | 1045 | (Page 1046) | 1047 | 1048 | .... | 1118 | newer